New and emerging modalities (neuromodulation, psychedelics etc.)

AI and advanced technologies enhance health solutions and promote equity

Traditional drugs + software to enhance clinical benefits

Digital Therapeutics

Funding innovation, creating, and extracting value

How AI is fueling disruption in the investment world

Corporate innovation management models (internal/external)

Strategies for successful Exits, M&As, IPOs,...

4Ps of Self-care; personal, preventive, predictive and precise healthcare​

Remote diagnostics and digital biomarkers that enable it​

Longevity strategies to improve health-span, not just lifespan

Genomics, biomarkers, and AI to develop targeted therapies

Tech integration for seamless hybrid care models (i.e. click & brick)

Virtual care and digitally-enhanced care pathways

AI and sensors to enhance hybrid healthcare delivery

Bridging the digital divide to improve health equity and create greater access

AI-driven, hybrid sales models to seamlessly integrate virtual and in-person engagement

Power of simultaneous global launches to accelerate market access while adapting to local and regional needs

Intelligent automation to streamline pharma workflows from MLR to training simulations and more

Consumer-first pharma models reshape engagement models and improve accessibility

Reimbursement and access pathways

FDA and EU support drug-software combinations for better outcomes

Health Data Space and AI Care Act

Enabling systemic innovation, from policy to practice

Private/public partnerships

Public initiatives foster open and collaborative innovation

Accelerators and incubators

Strategic ecosystems and partnerships to provide comprehensive care

Evolving translational science, accelerated by AI-driven innovations

Advanced knowledge mining to enhance translational research

Gen-AI and SynBio in biomedical R&D, including AI-powered drug repurposing and in silico drug discovery for personalized medicine etc.

Reimagining clinical trials by integrating omics technologies